Composition comprising antistatic polymer for room-temperature storage of biologically derived lipid bilayer structures

The combination of biologically derived lipid bilayer structures with an electrostatic inhibitory polymer like polyaniline stabilizes exosomes at room temperature, addressing structural and functional degradation issues, enabling long-term preservation and improved distribution.

WO2026235227A1PCT designated stage Publication Date: 2026-11-12TURINAX INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/KR2025/010654
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-09
Filing Date
2025-07-18
Publication Date
2026-11-12

AI Technical Summary

Technical Problem

Biologically derived lipid bilayer structures, such as exosomes, are prone to structural damage and functional degradation due to electrical instability, making long-term storage at room temperature or refrigeration challenging, and freezing causes additional structural damage during thawing.

Method used

A composition comprising biologically derived lipid bilayer structures, like exosomes, combined with an electrostatic inhibitory polymer, particularly polyaniline, maintains structural stability and biological function by suppressing fusion and aggregation, allowing storage at room temperature for over a year.

Benefits of technology

The composition effectively preserves the structural integrity and biological activity of exosomes for extended periods at room temperature, enhancing distribution convenience and industrial applicability.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure KR2025010654_12112026_PF_FP_ABST
    Figure KR2025010654_12112026_PF_FP_ABST
Patent Text Reader

Abstract

The present invention relates to a room-temperature storage composition for stable long-term storage of biologically derived lipid bilayer structures, such as exosomes and liposomes, and a method for preparing the composition. The composition comprises an antistatic polymer to prevent electrical aggregation between the structures and, in particular, comprises polyaniline, thereby allowing the structure and function of the lipid bilayer structures to be stably maintained for 12 months or longer even at room temperature. The composition of the present invention exhibits an exosome retention rate approximately 2.8 million times higher than that of physiological saline, and maintains biological activity. The exosomes may be isolated from various sources such as dermal papilla cells, stem cells, and body fluids, using various isolation techniques such as TFF.
Need to check novelty before this filing date? Find Prior Art

Description

A biologically derived lipid bilayer structure room temperature preservation composition containing an electrostatic suppression polymer

[0001] The present invention relates to a composition for stably storing a biologically derived lipid bilayer structure at room temperature for a long period of time and a method for manufacturing the same.

[0002] Nanoparticle structures possessing a lipid bilayer structure, either biologically derived or generated in a biomimetic manner, include exosomes, liposomes, micelles, microvesicles, aphototic bodies, oncosomes, and ectosomes. These structures possess a lipid bilayer membrane composed of phospholipids, protect internal components (proteins, RNA, drugs, etc.) from the external environment, and perform intercellular delivery functions. Depending on their size and composition, they exhibit diverse physiological functions and are applied in various fields, such as biological signal transduction, regulation of immune responses, and drug delivery.

[0003] Among them, exosomes are nanoparticles with a lipid bilayer structure secreted by cells that contain bioactive substances such as miRNA and proteins, and can regulate the activity and properties of recipient cells by delivering them to other cells. Due to these characteristics, exosomes are attracting attention as highly promising raw materials in the fields of cosmetics and pharmaceuticals.

[0004] However, exosomes are susceptible to structural damage as their outer membranes consist of a lipid bilayer, which can easily fuse or collapse due to electrical properties. Consequently, it is difficult to preserve them stably for about 7 days at room temperature or for more than 1 month even under refrigeration (4°C). Generally, freezing at -80°C or below has been utilized to ensure the structural stability of exosomes, and this method has the advantage of enabling preservation for a relatively long period. However, freezing has a critical disadvantage in that the structure of exosomes may be damaged during the thawing process. Furthermore, thawing is required right before use, and freezing facilities are required during storage and distribution, which limits its practicality and economic feasibility.

[0005] Accordingly, there is a growing need for new technology that can stably store lipid bilayer structures derived from organisms, such as exosomes, for a long period at room temperature without structural damage.

[0006] <Prior Art Literature>

[0007] <Patent Document 1> Korean Registered Patent No. 10-2660197

[0008] The present invention aims to provide a composition and a method for preparing the same that can be stored at room temperature while maintaining the structural stability and biological activity of biologically derived lipid bilayer structures, such as exosomes, liposomes, micelles, microvesicles, apoptotic bodies, oncosomes, and ectosomes, for a long period of time.

[0009] More specifically, another objective is to solve the problem where the above structures easily aggregate or collapse due to electrical instability in the lipid bilayer characteristics, thereby damaging the structure or degrading the function, to avoid disadvantages such as structural damage occurring during the thawing process in frozen storage, and to improve distribution convenience and industrial applicability by maintaining the particle stability and function of the biologically derived lipid bilayer structure for more than 12 months even at room temperature.

[0010] In addition, the present invention is applicable to exosomes isolated from various biologically derived samples, such as hair papilla cells and stem cells, and addresses the problem of improving room temperature preservation using an electrostatic inhibitory polymer, particularly polyaniline.

[0011] The room temperature preservation composition of the present invention comprises a biologically derived lipid bilayer structure and an electrostatic inhibitory polymer.

[0012] The biologically derived lipid bilayer structure of the present invention may be any one selected from exosomes, liposomes, micelles, microvesicles, aphototic bodies, oncosomes, and ectosomes.

[0013] The electrostatic suppressor polymer of the present invention is polyaniline.

[0014] The weight ratio of the biologically derived lipid bilayer structure and the electrostatic suppression polymer of the present invention is 2:1 to 1:2.

[0015] The exosomes of the present invention are isolated from dermal papilla cells.

[0016] The present invention comprises the steps of isolating exosomes from a biologically derived sample, preparing a polyaniline electrostatic inhibitory polymer solution, and mixing the isolated exosomes into the polyaniline electrostatic inhibitory polymer solution.

[0017] According to the present invention, a composition can be provided that allows a biologically derived lipid bilayer structure containing exosomes to be stored stably for a long period of time, for more than one year, at room temperature.

[0018] The composition of the present invention includes an electrostatic suppressing polymer, thereby suppressing fusion or aggregation between particles and maintaining the structural stability and biological function of the lipid membrane for a long period at room temperature.

[0019] In addition, the present invention is applicable not only to exosomes but also to various biologically derived lipid bilayer structures such as liposomes, micelles, microvesicles, aphototic bodies, oncosomes, and ectosomes, and can significantly improve the efficiency of preservation and distribution in industrial application fields such as cosmetics, pharmaceuticals, cell therapies, and drug delivery systems.

[0020] In particular, while additives previously used for exosome preservation had the limitation of potentially degrading the function of exosomes, the electrostatic suppression polymer of the present invention has the effect of ensuring stability without degrading function.

[0021] Figure 1 is a cryo-TEM image of an exosome according to an embodiment of the present invention.

[0022] Figure 2 is a graph of the number of exosome particles over time measured via NTA.

[0023] Figure 3 is a graph showing the change in cell number when fibroblasts were treated with 100 µl of exosomes for 3 days.

[0024] For convenience, specific terms are defined herein to facilitate a better understanding of the present invention. Unless otherwise defined herein, scientific and technical terms used in this invention shall have the meanings generally understood by those skilled in the art. Furthermore, unless specifically indicated in the context, terms in their singular form shall be understood to include their plural form, and terms in their plural form shall be understood to include their singular form.

[0025]

[0026] The present invention relates to the long-term preservation of a biologically derived lipid bilayer structure at room temperature.

[0027] In the present invention, a biologically derived lipid bilayer structure refers to a nanoparticle having a lipid bilayer structure formed in a biologically derived or biomimetic manner, and is any one selected from exosomes, liposomes, micelles, microvesicles, aphototic bodies, oncosomes, and ectosomes. Exosomes have lower structural stability compared to other lipid-based nanoparticles and are at a high risk of damage during storage because they contain bioactive substances (RNA, proteins, etc.) inside. In particular, long-term storage is especially difficult compared to liposomes or micelles because lipid membrane fusion and the decomposition of contents occur easily at room temperature.

[0028] The present invention utilizes a polymer having an electrostatic inhibition function to effectively suppress aggregation or fusion between lipid bilayer structures and to maintain structural stability and biological function for a long period even under room temperature storage conditions. In the present invention, the electrostatic inhibition polymer may be polyaniline, polypyrrole (PPy), or PEDOT:PSS (poly(3,4-ethylenedioxythiophene)-polystyrenesulfonate). In particular, polyaniline is suitable for the present invention as it exhibits excellent dispersibility under water-soluble acidic conditions, effectively disperses electrostatic attraction between lipid bilayer structures to prevent aggregation or fusion, and ensures stability during biological application.

[0029] In the present invention, exosomes may be isolated from dermal papilla cells, but are not limited thereto, and exosomes isolated from various biologically derived cells such as mesenchymal stem cells, neurons, immune cells, and liver cells may also be used in the present invention. In addition, exosomes isolated from bodily fluids such as blood, urine, and saliva may also be utilized.

[0030] In the present invention, the weight ratio of the biologically derived lipid bilayer structure to the electrostatic inhibiting polymer may be 2:1 to 1:2. Preferably, the weight ratio of the biologically derived lipid bilayer structure to the electrostatic inhibiting polymer may be 1.5:1 to 1:1.5. More preferably, the weight ratio of the biologically derived lipid bilayer structure to the electrostatic inhibiting polymer may be 1.2:1 to 1:1.2.

[0031] In the present invention, when the biologically derived lipid bilayer structure is an exosome and the electrostatic suppressing polymer is polyaniline, the weight ratio of the exosome to the polyaniline may be 2:1 to 1:2. Preferably, the weight ratio of the exosome to the polyaniline may be 1.5:1 to 1:1.5. More preferably, the weight ratio of the exosome to the polyaniline may be 1.2:1 to 1:1.2. For example, the weight ratio of the exosome to the polyaniline may be 1:1 to 1:1.

[0032]

[0033] The present invention is a method for preserving exosomes at room temperature, comprising the steps of isolating exosomes from a biologically derived sample, preparing a polyaniline electrostatic inhibitory polymer solution, and mixing the isolated exosomes with the polyaniline electrostatic inhibitory polymer solution.

[0034] In the present invention, the biologically derived sample may be a hair papilla cell, but is not limited thereto, and may be obtained from various biologically derived cells such as mesenchymal stem cells, nerve cells, immune cells, liver cells, or from blood, urine, saliva, etc.

[0035] In the present invention, the step of separating lipid bilayer structures from biological samples can be performed using conventional techniques such as ultra-high-speed centrifugation, tangential flow filtration, size exclusion chromatography, and immunoaffinity purification. When the lipid bilayer structure is an exosome, exosomes can be separated in large quantities from dermal papilla cells with minimal structural damage through tangential flow filtration.

[0036] In the present invention, the polyaniline electrostatic suppressing polymer solution may be prepared by dissolving polyaniline in saline solution at a concentration of 0.2 to 10 g / L. Preferably, it may be prepared by dissolving polyaniline in physiological saline solution at a concentration of 0.5 to 8 g / L. More preferably, it may be prepared by dissolving polyaniline in physiological saline solution at a concentration of 4 to 6 g / L. As an example, it may be prepared by dissolving polyaniline in physiological saline solution at a concentration of 5 g / L.

[0037]

[0038] Examples

[0039] The present invention will be explained more specifically below by way of examples, but the present invention is not limited to these examples.

[0040] Example. Preparation of an exosome room temperature preservation composition

[0041] (1) Culture of dermal papilla cells and isolation of exosomes

[0042] In this embodiment, human dermal papilla cells were cultured to produce exosomes. For cell culture, a medium containing 10% exosome-depleted fetal bovine serum in DMEM medium was used, and the cells were cultured in an incubator at 37°C under 5% CO₂ conditions. The culture medium was replaced every 2 days for a total of 3 days, and the waste culture medium obtained during the culture process was collected. The collected waste culture medium was concentrated using a Tangential Flow Filtration (TFF) system and filtered using a filter with a cutoff of 100,000 Da to 500,000 Da.

[0043] The concentrate obtained through this process was identified as an exosome by confirming the detection of exosome-specific proteins such as CD63, CD9, and HSP90 through Western blot analysis after treatment with RIPA buffer.

[0044]

[0045] (2) Preparation of electrostatic suppression polymer solution and exosome mixing

[0046] Polyaniline was used as the electrostatic inhibitory polymer. Polyaniline was dissolved in physiological saline at a concentration of 5 g / L and filtered once using a 0.2 μm syringe filter. The previously isolated exosomes were mixed with the polyaniline electrostatic inhibitory polymer solution prepared in this way at a weight ratio of 1:1, sealed, and stored at room temperature. At this time, the final concentration of polyaniline was adjusted to 2.5 g / L. Figure 1 is a cryo-TEM image of exosomes according to an embodiment of the present invention.

[0047]

[0048] Experimental Example 1. Evaluation of the cell proliferation ability of exosomes in an exosome room temperature storage composition

[0049] Samples of the composition obtained in the example were opened immediately after mixing, 6 months, and 12 months later, respectively, and the number of exosome particles was measured by NTA analysis, and the results are listed in Table 1. As a control, exosomes were mixed with physiological saline at a 1:1 ratio and used as a comparative example. Figure 2 is a graph of the number of exosome particles over time measured by NTA.

[0050]

[0051] Comparative Example (Group 1: Control Group: n=3) Example (Group 2: Experimental Group: n=3) 0 months 1.06 x 10 9 ±5.04 x 10 7 1.04 10 9 ±5.86 x 10 7 6 months 3.53 x 10 4 ±5.60 x 10 3 8.90 x 10 8 ±4.58 x 10 7 12 months 2.94 x 10 2 ±25.18.17 x 10 8 ±1.53 x 10 7 Retention rate 2.79 x 10 -5%78.87%

[0052] As shown in Table 1 and Figure 2, at 0 months, the number of exosome particles in the Comparative Example (Group 1) and the Example (Group 2) was found to be almost identical. After 6 months, it was found that the exosomes in the Comparative Example (Group 1) were destroyed, whereas the exosomes in the composition according to the present invention in the Example (Group 2) were almost maintained. After 12 months, it was found that most of the exosomes in the Comparative Example (Group 1) had disappeared, whereas the exosomes in the composition according to the present invention in the Example (Group 2) showed a 1-year preservation rate of 78.87%, which is significantly higher than that of the control group. From this, it can be confirmed that the composition of the present invention has the effect of preserving exosomes for a long period of time, more than 1 year, at room temperature.

[0053] Experimental Example 2. Evaluation of the cell proliferation ability of exosomes in an exosome room temperature storage composition

[0054] To confirm the biological activity of exosomes in the composition obtained in the examples, the proliferation rates were compared after treating fibroblasts with exosomes. 100 μL of exosomes was taken from each preservation sample and fibroblasts (3 x 10⁶) 8 After treating the cells for 3 days, the number of cells was measured, and the results are shown in Table 2 below. A graph showing the change in the number of cells is plotted in Figure 3.

[0055]

[0056] Comparative Example (Group 1: Control Group: n=3) Example (Group 2: Experimental Group: n=3) Cell Number Growth Rate Cell Number Growth Rate 0 months 5.29 x 10 6 ±1.21 x 10 5 176 % 5.26 x 10 6 ±2.18 x 10 5 175% 6 months 4.13 x 10 6 ±2.75 x 10 5 138 %4.61 x 10 6 ±9.67 x 10 4 154% 12 months 3.85 x 10 6±2.30 x 10 5 128 %4.50 x 10 6 ±2.87 x 10⁻⁶ 5 150%

[0057] As shown in Table 2, at 0 months, it can be confirmed that exosomes in both the Comparative Example (Group 1) and the Example (Group 2) exhibit almost the same proliferation effect shortly after being isolated from cells. However, after 6 months, the proliferation rate of the Comparative Example (Group 1) was 138%, whereas the proliferation rate of the composition of the Example (Group 2) of the present invention was 154%, indicating a higher proliferation rate. After 12 months, the proliferation rate of the Comparative Example (Group 1) was 128%, whereas the proliferation rate of the composition of the Example (Group 2) of the present invention was 150%, indicating a higher proliferation rate. This implies that the cell proliferation-promoting function of the exosomes in the composition of the Example (Group 2) of the present invention is superior. From this, it can be confirmed that the composition of the present invention has the effect of maintaining not only the structural stability of exosomes but also their biological activity for a long period.

[0058] The present invention has been described above with reference to its preferred embodiments. Those skilled in the art will understand that the present invention may be embodied in modified forms without departing from the essential characteristics of the invention. Therefore, the disclosed embodiments should be considered in an illustrative rather than a restrictive sense. The scope of the invention is defined by the claims, not by the foregoing description, and all variations within the scope of the claims should be interpreted as being included in the invention.

Claims

1. A bio-derived lipid bilayer structure room temperature preservation composition comprising a bio-derived lipid bilayer structure and an electrostatic inhibitory polymer.

2. In Paragraph 1, A biologically derived lipid bilayer structure room temperature preservation composition characterized in that the above biologically derived lipid bilayer structure is any one selected from exosomes, liposomes, micelles, microvesicles, aphototic bodies, oncosomes, and ectosomes.

3. In Paragraph 1, A biologically derived lipid bilayer structure room temperature preservation composition characterized in that the above-mentioned electrostatic suppression polymer is polyaniline.

4. In Paragraph 1, A biologically derived lipid bilayer structure room temperature preservation composition characterized by a weight ratio of the biologically derived lipid bilayer structure and the electrostatic suppression polymer being 2:1 to 1:

2.

5. In Paragraph 2, A biologically derived lipid bilayer structure room temperature preservation composition characterized by the exosomes being isolated from dermal papilla cells.

6. In Paragraph 5, The above exosomes contain 1 x 10 per 1 mL 9 Pieces up to 1 x 10 12 A biologically derived lipid bilayer structure room temperature preservation composition characterized by including a dog.

7. Step of isolating exosomes from a biologically derived sample, A method for preserving exosomes at room temperature, comprising the steps of preparing a polyaniline electrostatic inhibiting polymer solution and mixing isolated exosomes into the polyaniline electrostatic inhibiting polymer solution.

8. In Paragraph 7, A method for preserving exosomes at room temperature, characterized by using a tangential flow filtration method for the step of isolating exosomes from a biologically derived sample.

9. In Paragraph 7, A method for preserving exosomes at room temperature, characterized in that the concentration of the above-mentioned polyaniline electrostatic suppressing polymer solution is 0.1 g / L to 5 g / L.

10. In Paragraph 7, A method for preserving exosomes at room temperature, characterized by a weight ratio of exosomes to a polyaniline electrostatic inhibitory polymer of 2:1 to 1:2.